1. Home
  2. VTRS vs AYI Comparison

VTRS vs AYI Comparison

Compare VTRS & AYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • AYI
  • Stock Information
  • Founded
  • VTRS 1961
  • AYI 2001
  • Country
  • VTRS United States
  • AYI United States
  • Employees
  • VTRS N/A
  • AYI N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • AYI Building Products
  • Sector
  • VTRS Health Care
  • AYI Consumer Discretionary
  • Exchange
  • VTRS Nasdaq
  • AYI Nasdaq
  • Market Cap
  • VTRS 10.2B
  • AYI 8.5B
  • IPO Year
  • VTRS N/A
  • AYI N/A
  • Fundamental
  • Price
  • VTRS $8.83
  • AYI $273.03
  • Analyst Decision
  • VTRS Hold
  • AYI Hold
  • Analyst Count
  • VTRS 5
  • AYI 4
  • Target Price
  • VTRS $10.40
  • AYI $320.75
  • AVG Volume (30 Days)
  • VTRS 16.2M
  • AYI 262.1K
  • Earning Date
  • VTRS 08-07-2025
  • AYI 06-26-2025
  • Dividend Yield
  • VTRS 5.42%
  • AYI 0.25%
  • EPS Growth
  • VTRS N/A
  • AYI 10.20
  • EPS
  • VTRS N/A
  • AYI 13.18
  • Revenue
  • VTRS $14,330,200,000.00
  • AYI $3,958,300,000.00
  • Revenue This Year
  • VTRS N/A
  • AYI $14.03
  • Revenue Next Year
  • VTRS $1.89
  • AYI $10.21
  • P/E Ratio
  • VTRS N/A
  • AYI $20.72
  • Revenue Growth
  • VTRS N/A
  • AYI 2.78
  • 52 Week Low
  • VTRS $6.85
  • AYI $216.81
  • 52 Week High
  • VTRS $13.55
  • AYI $345.30
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 51.17
  • AYI 57.22
  • Support Level
  • VTRS $8.66
  • AYI $266.24
  • Resistance Level
  • VTRS $9.19
  • AYI $282.92
  • Average True Range (ATR)
  • VTRS 0.23
  • AYI 6.03
  • MACD
  • VTRS -0.01
  • AYI 0.29
  • Stochastic Oscillator
  • VTRS 48.11
  • AYI 66.92

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About AYI Acuity Brands Inc.

Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. Acuity, Inc. designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity, Inc. has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.

Share on Social Networks: